All studies
RecruitingNAINTERVENTIONAL

Interest of Morphokinetic Parameters of Early Embryonic Development in the Birth Rates in Vitro Fertilization

This study aims to find the best way to choose embryos during IVF treatment, a process where eggs are fertilised outside the body. In France, many children are born through IVF, but improving success rates by carefully selecting the best embryo to transfer is still a focus. Traditionally, embryos are chosen based on how they look at a specific moment. However, this study is investigating a newer method called 'morphokinetics'. This method uses special technology to continuously watch the embryo grow and develop, providing more information than just a single snapshot. Researchers want to see if using these detailed growth patterns, alongside how the embryo looks, can lead to higher chances of a successful pregnancy and birth compared to the older method.

At a glance

Status
Recruiting
Phase
NA
Sponsor
University Hospital, Rouen
Enrolment target
520
Start
26 Oct 2020
Estimated completion
01 Jun 2029

What is this study about?

This research is all about improving the chances of having a baby through IVF, which stands for In Vitro Fertilisation. IVF is a common fertility treatment where an egg is fertilised by sperm outside the body in a lab, and then the resulting embryo is placed back into the mother's womb. A really important part of IVF is choosing the 'best' embryo to put back, as this can increase the likelihood of pregnancy.

Traditionally, doctors pick an embryo by looking at it under a microscope at certain times. They judge it based on its appearance. However, this study is exploring a more advanced way of choosing embryos called 'morphokinetics'. This method uses special cameras and technology to continuously monitor the embryo's development from the moment it's created. This means doctors can see exactly how and when the embryo is growing, rather than just getting a snapshot at one point. The idea is that this continuous information might give a better idea of which embryo is most likely to lead to a successful pregnancy.

Why does this matter? Well, choosing the right embryo is key to making IVF more successful. If doctors can identify the strongest embryos, it could mean a better chance of getting pregnant and having a healthy baby. This study aims to find out if using this 'morphokinetic' information, which looks at the speed and pattern of an embryo's growth, is better than just looking at its appearance at specific times. The results could help more couples have the family they dream of.

Key takeaways

  • The study investigates ways to improve IVF success by better embryo selection.
  • It compares traditional embryo choice with a new method called 'morphokinetics'.
  • Morphokinetics involves continuously watching embryo development, not just snapshots.
  • The goal is to see if this new method leads to higher birth rates.
  • Eligibility is for couples undergoing IVF for male infertility, meeting specific age and health criteria.
  • Participation involves your standard IVF cycle, with a focus on how embryos are chosen.

Who may be eligible?

To take part in this study, you and your partner would need to be 18 years old or older. For women, you would need to be between 18 and 42 years old, and for men, between 18 and 59 years old. Both of you would need to be covered by a social security healthcare scheme in France and be able to understand and sign consent forms in French.

This study is specifically for couples undergoing their first or second IVF attempt because of male infertility. This means the man in the couple has sperm that isn't quite as healthy as it could be, affecting its number, concentration, movement, or shape. Importantly, the IVF attempt needs to use fresh sperm that has been ejaculated, not sperm taken directly from the testicles or epididymis (a tube near the testicles), or sperm that was previously frozen or collected due to a specific issue called retrograde ejaculation. Also, if the man has very few sperm (less than 100,000 per ejaculate), you wouldn't be able to join.

You also wouldn't be able to participate if you've been in a similar study called "EMCIMO" before, or if either you or your partner are currently under certain legal protections or unable to make your own decisions (like being under guardianship).

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are both you and your partner 18 years or older?
  2. Is the woman in the couple between 18 and 42, and the man between 18 and 59?
  3. Are you having IVF because of male infertility (sperm issues)?
  4. Is this your first or second IVF attempt?
  5. Are you using fresh, ejaculated sperm for your IVF treatment?
  6. Do both you and your partner understand French and can sign consent forms?
Answer every question to see your result.

What does participation involve?

The detailed information about what taking part involves is not provided in this summary. However, in a typical clinical trial of this nature, you would likely undergo your standard IVF treatment cycle. The main difference would be how the embryos are chosen for transfer. Researchers would be carefully observing your embryos using the special time-lapse technology mentioned, and the information from this monitoring would be used to select which embryo to transfer. There are no mentions of extra visits or medications beyond what's part of a standard IVF cycle for male infertility. The duration of your participation would cover your IVF treatment cycle, and researchers would then follow up to see if a pregnancy and birth occurred.

Potential risks and benefits

There are no direct medical benefits to you specifically mentioned in taking part, as the study is comparing different ways of selecting embryos rather than testing a new treatment. However, your participation could help doctors understand the best way to choose embryos for IVF, which might benefit future patients. The main risk would be the IVF procedure itself, which carries standard risks like any medical procedure, though this study isn't changing the IVF process itself, just the embryo selection. You would always have the right to withdraw from the study at any time without affecting your medical care.

Locations (2)

  • CHU CAEN
    Verified postcode
    Caen, France· Recruiting
  • Chu Rouen
    Verified postcode
    Rouen, France· Recruiting

Common questions

What is IVF?

IVF stands for In Vitro Fertilisation. It's a fertility treatment where an egg is fertilised by sperm outside the body in a laboratory. The resulting embryo is then carefully placed back into the mother's womb to hopefully grow into a baby.

What does 'morphokinetic parameters' mean?

This refers to observing how an embryo develops over time, including the speed and patterns of its growth. Instead of just looking at the embryo at one point, special technology watches its entire early development in detail.

Why is embryo selection important in IVF?

Choosing the best embryo to transfer is crucial because it can significantly increase the chances of a successful pregnancy and birth. Doctors want to pick the embryo most likely to implant and grow healthily.

Will taking part in this study change my IVF treatment?

The study aims to compare different methods of selecting embryos. Your overall IVF treatment plan for male infertility would likely remain the same, but the way your embryos are chosen for transfer might differ based on the study's approach.

Will I know if my embryo was chosen using the new method?

This detailed information isn't provided here, but if you join a study like this, you should always ask the research team for clear information about how your embryos will be selected and if you will know which method was used for your transfer.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Interest of Morphokinetic Parameters of Early Embryonic Deve…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.